THE ECONOMIC IMPACT OF IMPLEMENTING A MULTIPLE INFLAMMATORY BIOMARKER-BASED APPROACH TO IDENTIFY, TREAT, AND REDUCE CARDIOVASCULAR RISK

被引：0
|
作者：
Penn, M. S. [1 ]
Yenikomshian, M. A. [2 ]
Cummings, A. K. G. [2 ]
Damron, J. M. [2 ]
Purvis, S. [1 ]
Birnbaum, H. G. [2 ]
机构：
[1] Cleveland HeartLab Inc, Cleveland, OH USA
[2] Anal Grp Inc, Boston, MA USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.627
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV33
引用
收藏
页码：A107 / A107
页数：1
相关论文
共 33 条
  • [1] The economic impact of implementing a multiple inflammatory biomarker-based approach to identify, treat, and reduce cardiovascular risk
    Penn, M. S.
    Yenikomshian, M. A.
    Cummings, A. K. G.
    Klemes, A.
    Damron, J. M.
    Purvis, S.
    Beidelschies, M.
    Birnbaum, H. G.
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (07) : 483 - 491
  • [2] Knowledge of an inflammatory biomarker of cardiovascular risk leads to biomarker-based decreased risk in pre-diabetic and diabetic patients
    Alcivar-Franco, Diego
    Purvis, Scott
    Penn, Marc S.
    Klemes, Andrea
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (01)
  • [3] DEVELOPMENT AND VALIDATION OF A BIOMARKER-BASED CARDIOVASCULAR RISK PREDICTION SCORE IN RHEUMATOID ARTHRITIS
    Curtis, J.
    Xie, F.
    Crowson, C. S.
    Mabey, B.
    Flake, D.
    Bamford, R.
    Chin, C.
    Sasso, E.
    Hitraya, E.
    Ben-Shachar, R.
    Gutin, A.
    Lanchbury, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 874 - 875
  • [4] Derivation and Validation of a Biomarker-Based Cardiovascular Risk Prediction Score in Rheumatoid Arthritis
    Curtis, Jeffrey
    Xie, Fenglong
    Crowson, Cynthia
    Mabey, Brent
    Flake, Darl
    Bamford, Richard
    Chin, Cheryl
    Sasso, Eric
    Hitraya, Elena
    Gutin, Alexander
    Lanchbury, Jerry
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [5] Validation of Dynamic Biomarker-Based Risk Progression Model for Smoldering Multiple Myeloma
    Atrash, Shebli
    Robinson, Myra M.
    Aneralla, Amanda
    Brown, Taylor
    Friend, Reed
    Sprouse, Chelsea
    Ndiaye, Ami
    Zhang, Qing
    Lipford, Edward H.
    Block, Jared G.
    Smith, Elton T.
    Symanowski, James T.
    Avalos, Belinda Rene
    Copelan, Edward A.
    Voorhees, Peter M.
    Usmani, Saad Z.
    Bhutani, Manisha
    BLOOD, 2017, 130
  • [6] Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease
    Lindholm, Daniel
    Lindback, Johan
    Armstrong, Paul W.
    Budaj, Andrzej
    Cannon, Christopher P.
    Granger, Christopher B.
    Hagstrom, Emil
    Held, Claes
    Koenig, Wolfgang
    Ostlund, Ollie
    Stewart, Ralph A. H.
    Soffer, Joseph
    White, Harvey D.
    de Winter, Robbert J.
    Steg, Philippe Gabriel
    Siegbahn, Agneta
    Kleber, Marcus E.
    Dressel, Alexander
    Grammer, Tanja B.
    Maerz, Winfried
    Wallentin, Lars
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (07) : 813 - 826
  • [7] Biomarker-based risk score for prediction of cardiovascular events in stable coronary heart disease - Experiences from the STABILITY biomarker substudy
    Wallentin, L. C.
    Lindback, J.
    Held, C.
    Granger, C. B.
    Koenig, W.
    Stewart, R. A. H.
    Tarka, E.
    De Winter, R. J.
    White, H. D.
    Siegbahn, A.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1041 - 1042
  • [8] A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer's disease dementia
    Hartz, Sarah M.
    Mozersky, Jessica
    Schindler, Suzanne E.
    Linnenbringer, Erin
    Wang, Junwei
    Gordon, Brian A.
    Raji, Cyrus A.
    Moulder, Krista L.
    West, Tim
    Benzinger, Tammie L. S.
    Cruchaga, Carlos
    Hassenstab, Jason J.
    Bierut, Laura J.
    Xiong, Chengjie
    Morris, John C.
    ALZHEIMERS & DEMENTIA, 2023, 19 (04) : 1452 - 1465
  • [9] Impact of Biomarker-based Design Strategies on the Risk of False-Positive Findings in Targeted Therapy Evaluation
    Tat-Thang Vo
    Vivot, Alexandre
    Porcher, Raphael
    CLINICAL CANCER RESEARCH, 2018, 24 (24) : 6257 - 6264
  • [10] How does intensive blood pressure control reduce the risk of cardiovascular disease events? A biomarker-based mediation analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)
    Segar, Matthew
    Khan, Safi
    Nasir, Khurram
    Shafi, Tariq
    Januzzi, James
    Arora, Pankaj
    Butler, Javed
    Patel, Kershaw
    CIRCULATION, 2024, 150
1234